Cetera Advisors LLC Ginkgo Bioworks Holdings, Inc. Transaction History

Cetera Advisors LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$1.06 - $1.67 $39,966 - $62,965	37,704 Added 12.13%	348,543 $404,000
Q4 2023 Feb 13, 2024	BUY	$1.26 - $1.79 $34,030 - $48,344	27,008 Added 9.52%	310,839 $525,000
Q3 2023 Nov 14, 2023	BUY	$1.61 - $2.54 $165,289 - $260,766	102,664 Added 56.67%	283,831 $513,000
Q2 2023 Aug 09, 2023	BUY	$1.14 - $1.95 $116,952 - $200,050	102,590 Added 130.56%	181,167 $336,000
Q1 2023 May 15, 2023	BUY	$1.2 - $2.19 $44,614 - $81,422	37,179 Added 89.81%	78,577 $104,000
Q4 2022 Feb 14, 2023	BUY	$1.63 - $3.52 $67,478 - $145,720	41,398 New	41,398 $69,000

48M

Ticker DNA
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 1,287,779,968
Market Cap $19B
Description
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...

Get notified when there are updates to the investment portfolio of Cetera Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Cetera Advisors LLC with notifications on news.